The Global Health Technologies Coalition (GHTC) — consisting of 40 global health research and advocacy organizations — on Tuesday held a congressional briefing to launch its third annual policy report, titled “Sustaining Progress: Creating U.S. policies to spur global health innovation,” GlobalPost’s “Global Pulse” blog reports (Donnelly, 2/28). The group is “warning deep cuts in the U.S. federal budget could reverse progress made on many diseases, including HIV/AIDS, tuberculosis and malaria,” VOA News writes (DeCapua, 2/28).
Two new reports from southern Africa’s Health Systems Trust show that pregnant women, infants, and people newly diagnosed with HIV infection are receiving more services, but the costs of care are increasing, PlusNews reports. The annual District Health Barometer shows that about half of infants born to HIV-positive mothers are being tested for the virus at six weeks; almost all pregnant women are tested for HIV, helping to lower the rate of mother-to-child HIV transmission to below four percent nationwide; and about 70 percent of people newly diagnosed with HIV receive screening for tuberculosis (TB), according to the news service.
Examining Link Between ‘Power Structures,’ Disease Spread Through Study Of Incarceration, HIV Treatment
In this Open Society Foundations (OSF) blog post, Daniel Wolfe, director of the International Harm Reduction Development Program at OSF, examines “the ways that power structures, rather than individuals, contribute to disease rebound and spread,” citing a recent study by MJ Milloy and colleagues, published in the journal JAIDS, “which shows the link between incarceration and the failure of HIV treatment.” Wolfe writes, “Milloy’s analysis showed that incarceration kick-started viral replication among patients who had previously had their HIV under control. The findings make the study one of a number of must-reads on how prison practices not only impact the health of inmates but communities at large” (2/27).
Pharmaceutical company Novartis “has spoken out following criticism about its challenge to India’s patent laws, insisting that access to life-saving drugs is not under peril by the move,” Pharma Times World News reports. The case, which the Indian Supreme Court is scheduled to hear next month, challenges “Indian patent law, notably Section 3(d), which states that a modification of a known chemical composition is non-patentable,” the news service writes.
In this guest post in the Center for Global Health Policy’s “Science Speaks” blog, Brook Baker of the Northeastern University School of Law Program on Human Rights and the Global Economy, “describe[s] and comment[s] on pharmaceutical company Novartis’s court challenge to India’s strict standards of patenting medicine” and worldwide protests against the company that took place last week prior to its shareholder meeting (Mazzotta, 2/27).
“Cash-strapped Swaziland is struggling to fund its HIV programs, and experts are warning of long-term damage to treatment and prevention schemes if steps are not taken to ring-fence funding and supplies,” the Mail & Guardian reports. About 200,000 people are living with HIV in Swaziland, nearly one quarter of the population, the newspaper notes, adding, “Until now the government has done well in terms of providing antiretroviral (ARV) treatment — achieving 78 percent coverage, just under the World Health Organization’s ‘universal coverage’ rate of 80 percent. But there are fears that uncertainty about funding streams and weak supply-chain management could result in a reversal of this progress.” The article discusses funding from the government, PEPFAR, and the Global Fund to Fight AIDS, Tuberculosis and Malaria; antiretroviral drug and testing supply problems; and the epidemic’s effect on children and life expectancy in the country (Redvers, 2/27).
In this post in PSI’s “Healthy Living” blog, Mannasseh Phiri, PSI’s country representative in Zambia, examines HIV/AIDS in Zambian prisons. Phiri reports the findings of a survey recently conducted by the IN BUT FREE (IBF) Prisons Project “to determine the extent and magnitude of the HIV and AIDS epidemic in Zambia’s prisons.” He concludes, “The high prevalence of HIV in our prisons cannot and should not be ignored. We cannot hope to be able to tackle our HIV epidemic in Zambian society outside of the prisons, unless we face up to the reality of the HIV epidemic inside the prisons” (2/24).
“South Sudan’s army on Wednesday appealed for concerted efforts to fight against HIV/AIDS, stressing that the war against the sexually transmitted disease cannot be fought by one institution or group of some officials tasked by the government,” the Sudan Tribune reports. “Speaking in an interview with Sudan Tribune on Wednesday, Lieutenant Colonel John Woja, the HIV/AIDS Secretariat Program Manager of the military, warned that prevalence of disease poses a big threat to the military” and “called on media to complement the efforts of his directorate in sensitizing civilians and the army,” the newspaper writes.
“More than seven months overdue, the Global Fund to Fight AIDS, Tuberculosis and Malaria grant will finally be released to key South African AIDS organizations that have been struggling to survive,” PlusNews writes, adding, “Some were on the verge of shutting down.” According to the news service, “The Global Fund released US$7,106,426.91 to the South African National Treasury on February 6, the same day seven of the grant’s sub-recipients delivered an open letter to Minister of Health Aaron Motsoaledi, pleading for intervention.”
Approximately 85,000 HIV-positive people in Burma, also known as Myanmar, are in need of antiretroviral treatment (ART) and cannot access it “due to a lack of funding, despite renewed international engagement with the government amid a wave of political reform, according to a report released Wednesday” by the medical aid group Medecins Sans Frontieres (MSF), the Associated Press/CBS News reports (2/22). “At the launch of a new report called ‘Lives in the Balance,’ MSF said that only a quarter of the estimated 120,000 people living with HIV and AIDS were receiving treatment, and that it was turning people away from its clinics,” BBC News writes. While plans were made last year among MSF and its partners to scale up treatment for HIV and tuberculosis (TB), “those proposals were shelved after the Global Fund” to Fight AIDS, Tuberculosis and Malaria cancelled its Round 11 grants, according to the news agency. “The money was expected to provide HIV drugs for 46,500 people in Myanmar, along with treatment for another 10,000 people sicken[ed] by drug-resistant tuberculosis in the country, [the report] said,” BBC writes (Fisher, 2/22).